Literature DB >> 15304244

Heritability of circulating growth factors involved in the angiogenesis in healthy human population.

I Pantsulaia1, S Trofimov, E Kobyliansky, G Livshits.   

Abstract

The present study examined the extent of genetic and environmental influences on the populational variation of circulating growth factors (VEGF, EGF) involved in angiogenesis in healthy and ethnically homogeneous Caucasian families. The plasma levels of each of the studied biochemical indices were determined by enzyme-linked immunoassay in 478 healthy individuals aged 18-75 years. Quantitative genetic analysis showed that the VEGF and EGF variation was appreciably attributable to genetic effects, with heritability estimates of 79.9% and 48.4%, respectively. Yet, common environmental factors, shared by members of the same household, also played a significant role (P < 0.01) and explained between 20.1% and 32.6% of the variation. The present study additionally examined the covariations between these molecules and either transforming growth factor-beta 1 (TGF-beta 1) or tissue inhibitors of matrix metalloproteinases 1 (TIMP-1), likewise relevant for angiogenesis. Bivariate analysis revealed significant phenotypic correlations (P < 0.002) between all pairs of variables, thus indicating the possible existence of common genetic and environmental factors. The analysis suggested that the pleiotropic genetic effects were consistently the primary (or even the sole) source of correlation between all pairs of studied molecules. The results of our study affirm the existence of specific and common genetic pathways that commonly determine the greater part of the circulating variation of these molecules.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15304244     DOI: 10.1016/j.cyto.2004.04.005

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  12 in total

1.  Identification of cis- and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels.

Authors:  Stephanie Debette; Sophie Visvikis-Siest; Ming-Huen Chen; Ndeye-Coumba Ndiaye; Ci Song; Anita Destefano; Radwan Safa; Mohsen Azimi Nezhad; Douglas Sawyer; Jean-Brice Marteau; Vanessa Xanthakis; Gerard Siest; Lisa Sullivan; Michele Pfister; Holly Smith; Seung-Hoan Choi; John Lamont; Lars Lind; Qiong Yang; Peter Fitzgerald; Erik Ingelsson; Ramachandran S Vasan; Sudha Seshadri
Journal:  Circ Res       Date:  2011-07-14       Impact factor: 17.367

2.  Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib.

Authors:  Vincenzo Marotta; Concetta Sciammarella; Mario Capasso; Alessandro Testori; Claudia Pivonello; Maria Grazia Chiofalo; Rosario Pivonello; Luciano Pezzullo; Gerardo Botti; Annamaria Colao; Antongiulio Faggiano
Journal:  Endocrine       Date:  2016-12-16       Impact factor: 3.633

3.  Vascular endothelial growth factor, its soluble receptor, and hepatocyte growth factor: clinical and genetic correlates and association with vascular function.

Authors:  Wolfgang Lieb; Radwan Safa; Emelia J Benjamin; Vanessa Xanthakis; Xiaoyan Yin; Lisa M Sullivan; Martin G Larson; Holly M Smith; Joseph A Vita; Gary F Mitchell; Douglas B Sawyer; Ramachandran S Vasan
Journal:  Eur Heart J       Date:  2009-02-17       Impact factor: 29.983

Review 4.  Common polymorphisms in angiogenesis.

Authors:  Michael S Rogers; Robert J D'Amato
Journal:  Cold Spring Harb Perspect Med       Date:  2012-11-01       Impact factor: 6.915

5.  Genetics of VEGF serum variation in human isolated populations of cilento: importance of VEGF polymorphisms.

Authors:  Daniela Ruggiero; Cyril Dalmasso; Teresa Nutile; Rossella Sorice; Laura Dionisi; Mario Aversano; Philippe Bröet; Anne-Louise Leutenegger; Catherine Bourgain; Marina Ciullo
Journal:  PLoS One       Date:  2011-02-09       Impact factor: 3.240

Review 6.  Identifying Common Genetic Risk Factors of Diabetic Neuropathies.

Authors:  Ini-Isabée Witzel; Herbert F Jelinek; Kinda Khalaf; Sungmun Lee; Ahsan H Khandoker; Habiba Alsafar
Journal:  Front Endocrinol (Lausanne)       Date:  2015-05-28       Impact factor: 5.555

7.  Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies.

Authors:  Seung Hoan Choi; Daniela Ruggiero; Rossella Sorice; Ci Song; Teresa Nutile; Albert Vernon Smith; Maria Pina Concas; Michela Traglia; Caterina Barbieri; Ndeye Coumba Ndiaye; Maria G Stathopoulou; Vasiliki Lagou; Giovanni Battista Maestrale; Cinzia Sala; Stephanie Debette; Peter Kovacs; Lars Lind; John Lamont; Peter Fitzgerald; Anke Tönjes; Vilmundur Gudnason; Daniela Toniolo; Mario Pirastu; Celine Bellenguez; Ramachandran S Vasan; Erik Ingelsson; Anne-Louise Leutenegger; Andrew D Johnson; Anita L DeStefano; Sophie Visvikis-Siest; Sudha Seshadri; Marina Ciullo
Journal:  PLoS Genet       Date:  2016-02-24       Impact factor: 5.917

8.  Association of genetic polymorphisms in vascular endothelial growth factor with susceptibility to coronary artery disease: a meta-analysis.

Authors:  Wen-Qi Ma; Ying Wang; Xi-Qiong Han; Yi Zhu; Nai-Feng Liu
Journal:  BMC Med Genet       Date:  2018-07-04       Impact factor: 2.103

9.  What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications?

Authors:  Amélie Bonnefond; Pierre-Jean Saulnier; Maria G Stathopoulou; Niels Grarup; Ndeye Coumba Ndiaye; Ronan Roussel; Mohsen Azimi Nezhad; Aurélie Dechaume; Olivier Lantieri; Serge Hercberg; Torsten Lauritzen; Beverley Balkau; Julia S El-Sayed Moustafa; Torben Hansen; Oluf Pedersen; Philippe Froguel; Guillaume Charpentier; Michel Marre; Samy Hadjadj; Sophie Visvikis-Siest
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

Review 10.  Genetics, epigenetics and pharmaco-(epi)genomics in angiogenesis.

Authors:  Ian Buysschaert; Thomas Schmidt; Carmen Roncal; Peter Carmeliet; Diether Lambrechts
Journal:  J Cell Mol Med       Date:  2008-12       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.